Zentalis Pharmaceuticals (ZNTL) PT Raised to $94 at Stifel
Tweet
Share
E-mailGet Alerts ZNTL Hot Sheet
Price: $3.56 -14.22%
Rating Summary:
8 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Stifel analyst Bradley Canino raised the price target on Zentalis Pharmaceuticals (NASDAQ: ZNTL) to $94.00 (from $88.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zentalis Pharmaceuticals prices $80.5M public stock offering
- Sansera Engineering Ltd (SANSERA:IN) PT Raised to INR4,250 at ICICI Securities
- Zentalis Pharmaceuticals launches public stock offering
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
